PHARMACYCLICS INC's ticker is PCYC and the CUSIP is 716933106.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $126,000 | -25.4% | 1,033 | -28.4% | 0.00% | – |
Q3 2014 | $169,000 | +30.0% | 1,443 | -0.4% | 0.00% | – |
Q2 2014 | $130,000 | +188.9% | 1,449 | +224.2% | 0.00% | – |
Q1 2014 | $45,000 | +28.6% | 447 | +36.7% | 0.00% | – |
Q4 2013 | $35,000 | -28.6% | 327 | -7.1% | 0.00% | – |
Q3 2013 | $49,000 | – | 352 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 9,129,231 | $1,116,140,000 | 11.39% |
DAFNA Capital Management LLC | 110,928 | $13,562,000 | 10.73% |
HWG Holdings LP | 107,389 | $13,129,000 | 9.36% |
Opaleye Management Inc. | 85,000 | $10,392,000 | 5.25% |
Opus Point Partners Management, LLC | 25,723 | $3,145,000 | 3.11% |
BB BIOTECH AG | 731,542 | $89,438,000 | 2.90% |
Peregrine Asset Advisers, Inc. | 33,375 | $4,080,000 | 2.87% |
HARVEY CAPITAL MANAGEMENT INC | 54,770 | $6,696,000 | 2.57% |
Parametric Risk Advisors LLC | 300,000 | $36,678,000 | 2.45% |
BENDER ROBERT & ASSOCIATES | 28,619 | $3,499,000 | 2.29% |